Frequently asked questions and answers (if any) in patients with adrenal incidentaloma

PURPOSE: Adrenal incidentalomas (AIs) are incidentally discovered adrenal masses, during an imaging study undertaken for other reasons than the suspicion of adrenal disease. Their management is not a minor concern for patients and health-care related costs, since their increasing prevalence in the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceccato, F., Barbot, M., Scaroni, C., Boscaro, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572215/
https://www.ncbi.nlm.nih.gov/pubmed/34160793
http://dx.doi.org/10.1007/s40618-021-01615-3
_version_ 1784595177432678400
author Ceccato, F.
Barbot, M.
Scaroni, C.
Boscaro, M.
author_facet Ceccato, F.
Barbot, M.
Scaroni, C.
Boscaro, M.
author_sort Ceccato, F.
collection PubMed
description PURPOSE: Adrenal incidentalomas (AIs) are incidentally discovered adrenal masses, during an imaging study undertaken for other reasons than the suspicion of adrenal disease. Their management is not a minor concern for patients and health-care related costs, since their increasing prevalence in the aging population. The exclusion of malignancy is the first question to attempt, then a careful evaluation of adrenal hormones is suggested. Surgery should be considered in case of overt secretion (primary aldosteronism, adrenal Cushing’s Syndrome or pheochromocytoma), however the management of subclinical secretion is still a matter of debate. METHODS: The aim of the present narrative review is to offer a practical guidance regarding the management of AI, by providing evidence-based answers to frequently asked questions. CONCLUSION: The clinical experience is of utmost importance: a personalized diagnostic-therapeutic approach, based upon multidisciplinary discussion, is suggested.
format Online
Article
Text
id pubmed-8572215
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-85722152021-11-15 Frequently asked questions and answers (if any) in patients with adrenal incidentaloma Ceccato, F. Barbot, M. Scaroni, C. Boscaro, M. J Endocrinol Invest Original Article PURPOSE: Adrenal incidentalomas (AIs) are incidentally discovered adrenal masses, during an imaging study undertaken for other reasons than the suspicion of adrenal disease. Their management is not a minor concern for patients and health-care related costs, since their increasing prevalence in the aging population. The exclusion of malignancy is the first question to attempt, then a careful evaluation of adrenal hormones is suggested. Surgery should be considered in case of overt secretion (primary aldosteronism, adrenal Cushing’s Syndrome or pheochromocytoma), however the management of subclinical secretion is still a matter of debate. METHODS: The aim of the present narrative review is to offer a practical guidance regarding the management of AI, by providing evidence-based answers to frequently asked questions. CONCLUSION: The clinical experience is of utmost importance: a personalized diagnostic-therapeutic approach, based upon multidisciplinary discussion, is suggested. Springer International Publishing 2021-06-23 2021 /pmc/articles/PMC8572215/ /pubmed/34160793 http://dx.doi.org/10.1007/s40618-021-01615-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Ceccato, F.
Barbot, M.
Scaroni, C.
Boscaro, M.
Frequently asked questions and answers (if any) in patients with adrenal incidentaloma
title Frequently asked questions and answers (if any) in patients with adrenal incidentaloma
title_full Frequently asked questions and answers (if any) in patients with adrenal incidentaloma
title_fullStr Frequently asked questions and answers (if any) in patients with adrenal incidentaloma
title_full_unstemmed Frequently asked questions and answers (if any) in patients with adrenal incidentaloma
title_short Frequently asked questions and answers (if any) in patients with adrenal incidentaloma
title_sort frequently asked questions and answers (if any) in patients with adrenal incidentaloma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572215/
https://www.ncbi.nlm.nih.gov/pubmed/34160793
http://dx.doi.org/10.1007/s40618-021-01615-3
work_keys_str_mv AT ceccatof frequentlyaskedquestionsandanswersifanyinpatientswithadrenalincidentaloma
AT barbotm frequentlyaskedquestionsandanswersifanyinpatientswithadrenalincidentaloma
AT scaronic frequentlyaskedquestionsandanswersifanyinpatientswithadrenalincidentaloma
AT boscarom frequentlyaskedquestionsandanswersifanyinpatientswithadrenalincidentaloma

Ejemplares similares